Response: comment on Structural and Functional Progression in the Early Manifest Glaucoma Trial, Öhnell H; Heijl A; Brenner L et al., Ophthalmology, 2016; 123: 1173-1180

Hanna Maria Öhnell

Response: comment on Structural and Functional Progression in the Early Manifest Glaucoma Trial, Öhnell H; Heijl A; Brenner L et al., Ophthalmology, 2016; 123: 1173-1180

Ophthalmology (Malmö)

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	18-19
Journal	International Glaucoma Review
Volume	17
Issue number	4
Publication status	Published - 2016 Apr

Subject classification (UKÄ)

Ophthalmology

1 Article

Structural and Functional Progression in the Early Manifest Glaucoma Trial.
Öhnell, H., Heijl, A., Brenner, L., Anderson, H. & Bengtsson, B., 2016, In: Ophthalmology. 123, 6, p. 1173-1180
Research output: Contribution to journal › Article › peer-review

Open Access
File
353 Downloads (Pure)

Cite this

@article{a006c5fde40a48cda1540a2497f260e2,

title = "Response: comment on Structural and Functional Progression in the Early Manifest Glaucoma Trial, {\"O}hnell H; Heijl A; Brenner L et al., Ophthalmology, 2016; 123: 1173-1180",

author = "{\"O}hnell, \{Hanna Maria\}",

year = "2016",

month = apr,

language = "English",

volume = "17",

pages = "18--19",

journal = "International Glaucoma Review",

issn = "1566-1040",

publisher = "Kugler Publications",

number = "4",

}

TY - JOUR

T1 - Response

T2 - comment on Structural and Functional Progression in the Early Manifest Glaucoma Trial, Öhnell H; Heijl A; Brenner L et al., Ophthalmology, 2016; 123: 1173-1180

AU - Öhnell, Hanna Maria

PY - 2016/4

Y1 - 2016/4

M3 - Letter

SN - 1566-1040

VL - 17

SP - 18

EP - 19

JO - International Glaucoma Review

JF - International Glaucoma Review

IS - 4

ER -

Response: comment on Structural and Functional Progression in the Early Manifest Glaucoma Trial, Öhnell H; Heijl A; Brenner L et al., Ophthalmology, 2016; 123: 1173-1180

Subject classification (UKÄ)

Research output

Structural and Functional Progression in the Early Manifest Glaucoma Trial.

Cite this